University of Pennsylvania
Behavioral impairments caused by anisomycin reverse with time
Published in Mental Health Law Weekly, June 19th, 2004
"Recent accounts of memory suggest that retrieval of a learning experience transforms that memory into a labile state that requires a period of protein synthesis to be reconsolidated into a fixed state. In this article, we show that the impairments in behavior caused by the protein synthesis inhibitor anisomycin given after retrieval are temporary and are thus not likely to reflect disruptions in a protein synthesis-dependent reconsolidation process," researchers in the United States report.
"Mice received...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
More Articles from Mental Health Law Weekly
- Accelerate Brain Cancer Cure
Alliance to boost research funding at St. Jude Children's Research Hospital - Criminology
Violence by criminal psychiatric patients after discharge is rare - Healthcare Fraud
Ex-lawmaker, former Braves pitcher indicted in fraud case - Memory Pharmaceuticals Corp.
CNS-focused company reports first quarter 2004 financial results - Mental Health
Arkansas to end program, send mentally ill acquitted of crimes for private treatment - Presidency College, West Bengal
Arsenic trioxide generates islet cell toxicity in rabbits - More from this issue of Mental Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
